ArticleProceedings of the National Academy of Sciences of the United States of America2024

Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.

Michael M Poon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.